Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexandre Eusebio

Showing results (51-60 of 82) with videos related to

Pageof 9
Sort By:
Neurobiology of Disease|June 18, 2018
Beta burst coupling across the motor circuit in Parkinson's diseaseGerd Tinkhauser, Flavie Torrecillos, Yann Duclos, et al.
Journal of Neurology|April 10, 2016
Quality of life in Parkinson's disease improved by apomorphine pump: the OPTIPUMP cohort studySophie Drapier, Alexandre Eusebio, Bertrand Degos, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|November 13, 2013
Rivastigmine in apathetic but dementia and depression-free patients with Parkinson's disease: a double-blind, placebo-controlled, randomised clinical trialDavid Devos, Caroline Moreau, David Maltête, et al.
Neurobiology of Disease|July 21, 2018
Deep brain stimulation does not enhance neuroinflammation in multiple system atrophyMiguel Lopez-Cuina, Pierre-Olivier Fernagut, Marie-Hélène Canron, et al.
Neurology|January 22, 2016
Long-term efficacy and tolerability of bilateral pallidal stimulation to treat tardive dyskinesiaHélène Pouclet-Courtemanche, Tiphaine Rouaud, Stephane Thobois, et al.
Parkinsonism & Related Disorders|October 10, 2018
Naftazone in advanced Parkinson's disease: An acute L-DOPA challenge randomized controlled trialJean-Christophe Corvol, Franck Durif, Wassilios G Meissner, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|January 31, 2024
A Double-Blind, Randomized, Placebo-Controlled Trial of Bumetanide in Parkinson's DiseasePhilippe Damier, Bertrand Degos, Giovanni Castelonovo, et al.
Parkinsonism & Related Disorders|August 6, 2025
Non-motor subtypes in candidates for subthalamic deep brain stimulation for Parkinson's diseaseHélène Ducrocq, Salomé Puisieux, Lucie Hopes, et al.
Journal of Parkinson'S Disease|May 24, 2020
Personality Dimensions Are Associated with Quality of Life in Fluctuating Parkinson's Disease Patients (PSYCHO-STIM)Mathilde Boussac, Christophe Arbus, Julia Dupouy, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|January 25, 2024
ON/OFF non-motor evaluation: a new way to evaluate non-motor fluctuations in Parkinson's diseaseFlorent Faggianelli, Tatiana Witjas, J-P Azulay, et al.
Pageof 9

Showing results (51-60 of 82) with videos related to

Sort By:
Pageof 9
Neurobiology of Disease|June 18, 2018
Beta burst coupling across the motor circuit in Parkinson's diseaseGerd Tinkhauser, Flavie Torrecillos, Yann Duclos, et al.
Journal of Neurology|April 10, 2016
Quality of life in Parkinson's disease improved by apomorphine pump: the OPTIPUMP cohort studySophie Drapier, Alexandre Eusebio, Bertrand Degos, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|November 13, 2013
Rivastigmine in apathetic but dementia and depression-free patients with Parkinson's disease: a double-blind, placebo-controlled, randomised clinical trialDavid Devos, Caroline Moreau, David Maltête, et al.
Neurobiology of Disease|July 21, 2018
Deep brain stimulation does not enhance neuroinflammation in multiple system atrophyMiguel Lopez-Cuina, Pierre-Olivier Fernagut, Marie-Hélène Canron, et al.
Neurology|January 22, 2016
Long-term efficacy and tolerability of bilateral pallidal stimulation to treat tardive dyskinesiaHélène Pouclet-Courtemanche, Tiphaine Rouaud, Stephane Thobois, et al.
Parkinsonism & Related Disorders|October 10, 2018
Naftazone in advanced Parkinson's disease: An acute L-DOPA challenge randomized controlled trialJean-Christophe Corvol, Franck Durif, Wassilios G Meissner, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|January 31, 2024
A Double-Blind, Randomized, Placebo-Controlled Trial of Bumetanide in Parkinson's DiseasePhilippe Damier, Bertrand Degos, Giovanni Castelonovo, et al.
Parkinsonism & Related Disorders|August 6, 2025
Non-motor subtypes in candidates for subthalamic deep brain stimulation for Parkinson's diseaseHélène Ducrocq, Salomé Puisieux, Lucie Hopes, et al.
Journal of Parkinson'S Disease|May 24, 2020
Personality Dimensions Are Associated with Quality of Life in Fluctuating Parkinson's Disease Patients (PSYCHO-STIM)Mathilde Boussac, Christophe Arbus, Julia Dupouy, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|January 25, 2024
ON/OFF non-motor evaluation: a new way to evaluate non-motor fluctuations in Parkinson's diseaseFlorent Faggianelli, Tatiana Witjas, J-P Azulay, et al.
Pageof 9